Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Biodefense market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.2% during the forecast period.
This report presents the market size and development trends by detailing the Biodefense market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Biodefense market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Biodefense industry and will help you to build a panoramic view of the industrial development.
Biodefense Market, By Type:
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
Biodefense Market, By Application:
US Military Market
US Civilian Market
Non - US Market
Some of the leading players are as follows:
PharmAthene
Ichor Medical Systems
SIGA Technologies
Aeolus Pharmaceuticals
DynPort Vaccine
Alnylam Pharmaceuticals
Soligenix
Sanofi
Bavarian Nordic
Arbutus Biopharma
Elusys Therapeutics
Emergent Biosolutions
GSK
Hytest
Dynavax Technologies
Achaogen
Cleveland BioLabs
Xoma Corporation
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Biodefense Market: Technology Type Analysis
-
4.1 Biodefense Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Biodefense Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Anthrax
4.3.2 Smallpox
4.3.3 Botulism
4.3.4 Radiation/Nuclear
4.3.5 Others
5 Biodefense Market: Product Analysis
-
5.1 Biodefense Product Market Share Analysis, 2018 & 2026
-
5.2 Biodefense Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Biodefense Market: Application Analysis
-
6.1 Biodefense Application Market Share Analysis, 2018 & 2026
-
6.2 Biodefense Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 US Military Market
6.3.2 US Civilian Market
6.3.3 Non - US Market
7 Biodefense Market: Regional Analysis
-
7.1 Biodefense Regional Market Share Analysis, 2018 & 2026
-
7.2 Biodefense Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 PharmAthene
9.1.1 PharmAthene Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Ichor Medical Systems
9.2.1 Ichor Medical Systems Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 SIGA Technologies
9.3.1 SIGA Technologies Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Aeolus Pharmaceuticals
9.4.1 Aeolus Pharmaceuticals Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 DynPort Vaccine
9.5.1 DynPort Vaccine Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Alnylam Pharmaceuticals
9.6.1 Alnylam Pharmaceuticals Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Soligenix
9.7.1 Soligenix Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Sanofi
9.8.1 Sanofi Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Bavarian Nordic
9.9.1 Bavarian Nordic Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Arbutus Biopharma
9.10.1 Arbutus Biopharma Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Elusys Therapeutics
9.11.1 Elusys Therapeutics Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Emergent Biosolutions
9.12.1 Emergent Biosolutions Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 GSK
9.13.1 GSK Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Hytest
9.14.1 Hytest Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Dynavax Technologies
9.15.1 Dynavax Technologies Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 Achaogen
9.16.1 Achaogen Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 Cleveland BioLabs
9.17.1 Cleveland BioLabs Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
9.18 Xoma Corporation
9.18.1 Xoma Corporation Company overview
9.18.2 Financial performance
9.18.3 Product benchmarking
9.18.4 Strategic initiatives
9.18.5 SWOT analysis
The List of Tables and Figures (Totals 101 Figures and 135 Tables)
Figure Anthrax Biodefense market, 2015 - 2026 (USD Million)
Figure Smallpox Biodefense market, 2015 - 2026 (USD Million)
Figure Botulism Biodefense market, 2015 - 2026 (USD Million)
Figure Radiation/Nuclear Biodefense market, 2015 - 2026 (USD Million)
Figure Others Biodefense market, 2015 - 2026 (USD Million)
Figure US Military Market market, 2015 - 2026 (USD Million)
Figure US Civilian Market market, 2015 - 2026 (USD Million)
Figure Non - US Market market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Biodefense market, by country, 2015 - 2026 (USD Million)
-
Table North America Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table North America Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table North America Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table Canada Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table Canada Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Europe Biodefense market, by country, 2015 - 2026 (USD Million)
-
Table Europe Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table Europe Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table Europe Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table Germany Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table Germany Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table France Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table France Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table Italy Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table Italy Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table Spain Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table Spain Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Biodefense market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table China Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table China Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table Japan Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table Japan Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table India Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table India Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Biodefense market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table MEA Biodefense market, by country, 2015 - 2026 (USD Million)
-
Table MEA Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table MEA Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table MEA Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Biodefense market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Biodefense market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Biodefense market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table PharmAthene Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ichor Medical Systems Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table SIGA Technologies Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aeolus Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table DynPort Vaccine Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Alnylam Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Soligenix Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bavarian Nordic Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Arbutus Biopharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Elusys Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Emergent Biosolutions Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GSK Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hytest Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Dynavax Technologies Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Achaogen Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cleveland BioLabs Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Xoma Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
